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Introduction
Toxoplasma gondii is a universal prevalent protozoan 
parasite which infected all the warm-blooded animals 
such as humans (1). Human, usually, can be infected 
via three chief ways of transmission: consumption of 
tissue cysts in infected meat, consumption of food or 
water contaminated with oocysts and congenitally (2, 3). 
Toxoplasmosis in immunecompetent persons is seldom 
symptomatic. However, the disease happening in the fetus or 
immunocompromised individuals (transplant recipients and 
patients with acquired immunodeficiency syndrome) might 
cause serious symptoms or even passing away (4, 5). Today, 
the preferred treatment for toxoplasmosis is combination of 
pyrimethamine and sulfadiazine. Nevertheless, the use of 
these drugs is associated with some serious complications 
including osteoporosis, sepsis and also teratogenic effects (6, 
7). Since last centuries, herbal drugs have been considered 
as the main source for prevention and treatment a broad 
spectrum of illnesses as well as infectious ones (7).
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ABSTRACT
Since last centuries, herbal medicines have been considered as 
the main source for prevention and treatment a broad spectrum 
of illnesses as well as infectious diseases. Here we evaluated the in 
vivo activity of Berberis vulgaris methanolic root extract against 
acute toxoplasmosis induced by Toxoplasma gondii, RH strain. 
Male NMRI mice orally treated with B. vulgaris methanolic 
extract at the dose of 1 and 2 g/kg once a day for 14 days after 24 
h mice were infected intraperitoneally with 104 tachyzoites of T. 
gondii, RH strain. The mortality rate in all infected mice and also 
parasite load were determined to assess the efficacy B. vulgaris 
methanolic extract against acute toxoplasmosis in mice model. 
The obtained results demonstrated that the mortality rate of 
infected mice was 100%, in 9th day after orally administration of 
B. vulgaris at the concentrations of 1 and 2 g/kg; while all mice 
in the control group were death in 5th day. Moreover obtained 
findings revealed that the mean number of tachyzoites was 
131×104 and 79×104 for infected mice treated with B. vulgaris 
at the concentrations of 1 and 2 g/kg, respectively, whereas in 
control group the mean number of tachyzoites was 288×104 
parasite. The obtained findings demonstrated the potential 
of B. vulgaris as a natural source for the production of new 
prophylactic agent for use in toxoplasmosis.
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Berberis vulgaris L. called in Persian as “Zereshk” 
(Berberidaceae family) broadly growth in most countries in 
the world such as Iran (8). In traditional medicine, a variety 
of portions of B. vulgaris such as root, leaf, bark and fruit 
have been extensively applied for the healing a number of 
diseases such as skin, respiratory, cardiovascular, digestive, 
and infectious ones (9). Nowadays, reviews have reported 
a range of pharmacological possessions of B. vulgaris 
including antinociceptive, antioxidant, anti-inflammatory 
and antimicrobial effects (10). To the best of our knowledge 
and according to the literature review, there is no study on 
the effects of B. vulgaris against toxoplasmosis. Therefore, 
the current investigation aims to evaluate the efficacy of B. 
vulgaris root methanolic extract on infected mice with acute 
toxoplasmosis.
Materials and methods
Plant Collection
The B. vulgaris roots were obtained from the farms in the Baft 
district of Kerman province, Iran, in May 2016. The identities 
were confirmed by the botanist at the Botany Department of 
Shahid Bahonar University, Kerman, Iran. Voucher specimen 
(kf 585) of the plant materials was deposited at the Herbarium 
of Department of Pharmacognosy of the School of Pharmacy, 
Kerman University of Medical Science, Kerman, Iran.
Preparing of methanolic extract
Extraction of the dried roots (200 g) of B. vulgaris was 
performed percolation technique with methanol for 72 h 
in room temperature. The extract was moved among filter 
paper (Whatman No.3, Sigma, Germany) to take out plant 
remains. The extract was lastly concentrated in vacuum at 
50°C using a rotary evaporator (Heidolph, Germany) and 
kept at -20°C, until testing (11).
Ethical statements
This survey was done in line with the recommendations 
in the Guide for the Care and Use of Laboratory Animals 
of the National Institutes of Health. The protocol was 
approved by the Committee on the Ethics of Animal 
Experiments of the Bam University of Medical Science, 
Iran (No.218/2017)
Establishment of acute toxoplasmosis
Forty male NMRI mice (6–8 weeks old) weighing from 20 to 
25 g for establishing animal model of T. gondii were obtained 
from the Animal House of Kerman University of Medical 
sciences, Iran. Animals were housed in a colony room with 
a 12:12 h light/ dark cycle at 21 ± 2°C and were handled 
according to standard protocols for the use of laboratory 
animals. They were divided into four groups; every group 
contained ten mice. Animal model of acute toxoplasmosis 
was established according to the method described by Asgari 
et al (2013) using intraperitonealy injection 104 tachyzoite of 
T. gondii, RH strain (12).
Efficacy of B. vulgaris on acute toxoplasmosis
Mice were divided into four main groups (10 mice per each 
group) including: (1) non-treated control, (2) mice treated 
with normal saline for 14 days, (3) orally treated with B. 
vulgaris methanolic extract at the dose of 1 g/kg once a day 
for 14 days, (4) orally treated with B. vulgaris methanolic 
extract at the dose of 2 g/kg once a day for 14 days. In 15th day 
mice in all tested groups were infected T. gondii, RH strain 
as mentioned above. The selections of extract doses was 
based on primary expriments that showed B. vulgaris had 
no toxicity in mentioned doses. The subsequent factors were 
performed to determine the efficacy B. vulgaris methanolic 
extract against acute toxoplasmosis in mice model.
Mortality rate
The mortality rate was determined according to the following 
formula:
MR= 
Parasite load
Counting the mean number of T. gondii tachyzoites in the 
peritoneal fluid of mice. The extracellular tachyzoites in each 
mouse were counted in 10 high power field (HPF) and then 
the mean number of tachyzoites 10/HPF was estimated. Then 
the mean number of tachyzoites in each group of infected 
mice was calculated (13).
Statistical analysis
Data analysis was carried out using SPSS statistical package 
version 17.0 (SPSS Inc., Chicago, IL, USA). Differences 
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between test and control groups were analyzed by t-test. In 
addition, p<0.05 was considered statistically significant.
Results
In the present study we evaluated efficacy of B. vulgaris 
root methanolic extract against acute toxoplasmosis in 
mice model. As shown in Figure 1, the mortality rate of 
infected mice in the control group was 100% after 5th 
after establishment. The mortality rate of infected mice in 
group 3 was 100%, in 9th day after orally administration of 
B. vulgaris at the concentration of 1 g/kg; indicating that 
B. vulgaris significantly (p<0.05) increased the time of 
death in the infected mice. Similarly, the mortality rate of 
infected mice in group 4 was 100% in 9th day after orally 
administration of B. vulgaris at the concentration of 2 g/kg 
which demonstrated that B. vulgaris significantly (p<0.05) 
increased the time of death in the infected mice.
Figure 2 indicates the parasite load (mean number of 
tachyzoites) in tested groups. The mean number of 
tachyzoites was 131 × 104 and 79 × 104 for infected mice 
treated with 1 and 2 g/kg, respectively, whereas in control 
group the mean number of tachyzoites was 288×104 parasite. 
The obtained results showed that the difference in mortality 
rate between of B. vulgaris at the concentrations of 1 and 
2 g/kg in comparison to the control group was statistically 
significant (p<0.05).
Discussion
At present, there are a restricted number of agents for 
the treatment of toxoplasmosis and the combination of 
pyrimethamine and sulfadiazine is the most common 
(3). However, these drugs may results in some adverse 
effects, including osteoporosis, sepsis and also teratogenic 
effects particularly in persons with immunocompromised 
patients (2, 3). So far, efforts to decrease the toxicity of these 
compounds have been failed, that reinforces the requirement 
for novel anti-Toxoplasma drugs. Thus, studies that could 
offer a substitute therapy, condense dosages, treatment time 
and side effects for toxoplasmosis, would be greeting. Here 
we evaluated efficacy of B. vulgaris root methanolic extract 
against acute toxoplasmosis induced by RH strain T. gondii 
in mice model.
The obtained results demonstrated that the mortality rate of 
infected mice was 100%, in 9th day after orally administration 
of B. vulgaris at the concentrations of 1 and 2 g/kg; indicating 
that oral administration of B. vulgaris for 14 days especially at 
the aforementioned concentrations had potent prophylactic 
effects against acute toxoplasmosis in mice and their survival 
was prolonged to 9 days, while all mice in the control group 
were death in 5th day. Moreover obtained findings revealed 
that the mean number of tachyzoites was 131×104 and 79×104 
for infected mice treated with B. vulgaris at the concentrations 
of, respectively, whereas in control group the mean number 
of tachyzoites was 288×104 parasite; which indicated that B. 
Figure 1. Effects of orally administration of Berberis vulgaris methanolic root extract on mortality rate of infected mice with 
acute toxoplasmosis.
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vulgaris significantly reduce parasite load in infected mice 
with acute toxoplasmosis.
Reviews have reported that the main components of B. 
vulgaris are isoquinoline alkaloids such as berbamine, 
palmatine, and particularly berberine (10, 14). Previous 
investigations have shown antibacterial, anti candidal, and 
anti-dermatophyte activity of this plant due to having high 
amount of isoquinoline alkaloids (15-17). Furthermore, 
in several study anti-parasitic effects of B. vulgaris root 
extract have been demonstrated; for example in the study 
conducted by Mahmoudvand et al, it has been proven that B. 
vulgaris methanolic extract and berberine alone have high 
protoscolicidal effects against protoscoleces of Echinococcus 
granulosus in low concentration and short exposure time 
on in vitro model (18). Fata et al (19) have demonstrated 
that ethanolic extract of B. vulgaris considerably reduced 
ulcer size of cutaneous leishmaniasis of BALB/c mice after 
14 days.
Kaneda et al (20) have demonstrated that berberine notably 
condensed growth of Entamoeba histolytica, Giardia lamblia, 
and Trichomonas vaginalis on an in vitro model and result 
in morphological changes in their structure. Sheng et al 
(21) showed that, in chloroquine resistant malaria, the 
combination of berberine and pyrimethamine have a 
synergistic effect in the removal of parasites and it was 
further efficient than other drugs including tetracycline 
or cotrimoxazole. Moreover, Vennerstrom et al (22) have 
reported that berberine derivatives considerably concealed 
the parasite load in liver or ulcer size in golden hamsters 
infected with Leishmania donovani and Leishmania 
braziliensis when compared with meglumine antimoniate.
Regarding antimicrobial mechanisms of berberine, reviews 
have demonstrated that antifungal activity of berberine on 
Candida growth was most likely because of hang-up of both 
sterol and cell wall biosyntheses in this yeast (8). Moreover, 
Peng et al (23) reported that berberine can break the structure 
of bacterial cell wall and restrain synthesis of protein and 
DNA. With respect to toxicity effects of B. vulgaris and 
berberine reviews have shown that they are not considered 
toxic at the doses used in clinical studies, nor have they been 
revealed to be cytotoxic or mutagenic, whereas, their side 
effects can be increased to dose development (5, 24, 25).
Conclusion
The obtained results delivered the scientific suggestion that 
natural plants might be used in traditional medicine for 
the prevention and treatment of parasitic infections such 
as acute toxoplasmosis. However, additional investigations 
are needed to assess exact effect of B. vulgaris principally its 
immunomodulatory on acute toxoplasmosis.
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Figure 2. The mean number of T. gondii tachyzoites in the peritoneal fluid of infected mice following orally administration of 
Berberis vulgaris methanolic root extract
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Berberis vulgaris ekstraktının farelerde oluşturulan akut 
toksoplazmozis üzerine etkileri
ÖZ
Son birkaç yüzyıldır bitkisel kaynaklardan elde edilen ilaçlar 
çeşitli hastalıklarla birlikte enfeksiyon hastalıklarının da 
tedavisinde ve profilaksisinde kullanılmaktadır. Bu çalışmada; 
Berberis vulgaris’in köklerinden hazırlanan matanollü 
ekstrenin, Toxoplasma gondii RH suşuyla enfekte edilerek 
akut toksoplazmozis oluşturulmuş farelerdeki etkisi araştırıldı. 
Erkek NMRI fareleri intraperitoneal yoldan Toxoplasma gondii 
RH suşuna ait 104 taşizoitle enfekte edildikten 24 saat sonra 
bu farelere oral yoldan Berberis vulgaris’in ekstresi 1 ve 2 g/kg 
dozlarda, günde 1 kez, 14 gün boyunca uygulandı. Tüm farelerde 
ölüm oranı ve parazit yükü tespit edilerek akut toksoplazmoziste 
B. vulgaris’in metanollü ekstresinin etkisi belirlendi. Berberis 
vulgaris’in 1 ve 2 g/kg dozlarda oral yoldan uygulanmasının 
takip eden 9. günde farelerde ölüm oranı %100 olarak belirlendi, 
kontrol grubundaki bütün farelerin 5.günün sonunda öldüğü 
gözlendi. Berberis vulgaris’in 1 ve 2 g/kg dozlarda uygulandığı 
gruplarda ortalama taşizoit değeri sırasıyla 131×104 ve 79×104 
olarak saptanırken kontrol grubunda taşizoit sayısı ortalama 
288×104 parazit olarak belirlendi. Elde edilen sonuçlar 
dikkate alınarak B. vulgaris’in toksoplazmozis profilaksisinde 
kullanılabilecek bir ilacın üretiminde doğal kaynaklı bir bileşen 
olarak kullanılabilirliği gösterilmiştir.
Anahtar kelimeler: Toxoplasma gondii; Berberis vulgaris; 
Profilaksi; In vivo
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